Sandoz launches first generic version of ATACAND®

Princeton, New Jersey, May 22, 2013 - Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of candesartan cilexetil tablets, the first generic version of ATACAND®.

Novartis wins GBCHealth Business Action on Health Award for social ventures initiative

Basel, Switzerland, May 17, 2013 - Novartis is pleased to announce that GBCHealth, a coalition of more than 230 private sector companies working to improve global health, has awarded the company's Arogya Parivar program the Business Action on Health Award for Application of Core Competence. Arogya Parivar is a sustainable business model that makes affordable, high-quality medicines accessible to underserved millions in India. The program also expands access to health education and consultations in remote villages.

New episode of Sandoz TV available

May 13, 2013 - Sandoz has just launched its thirteenth episode of Sandoz TV.

Celebrating Novartis’ 17th Community Partnership Day

Holzkirchen, Germany, April 25, 2013 - On April 25th we celebrate Novartis’ 17th annual Community Partnership Day. This company-wide initiative, which encourages all associates to engage in volunteering for charitable causes, is another example of our long-standing commitment to being a responsible company.